Selected research
Market Structure
Global External Anthelmintic for Dogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global External Anthelmintic for Dogs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for External Anthelmintic for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for External Anthelmintic for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for External Anthelmintic for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for External Anthelmintic for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of External Anthelmintic for Dogs include FRONTLINE, Zoetis, Bayer, Virbac, Vetoquinol, NexGard, Merck Animal Health, Elanco and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global External Anthelmintic for Dogs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of External Anthelmintic for Dogs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents External Anthelmintic for Dogs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the External Anthelmintic for Dogs market size, projected growth trends, production technologies, key applications, and end-use industries.
External Anthelmintic for Dogs Segment by Company
FRONTLINE
Zoetis
Bayer
Virbac
Vetoquinol
NexGard
Merck Animal Health
Elanco
Boehringer Ingelheim
External Anthelmintic for Dogs Segment by Type
Spray
Drops
External Anthelmintic for Dogs Segment by Application
Research Institutions
Veterinary Clinics
Animal Shelters
Pet Owners
Others
External Anthelmintic for Dogs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global External Anthelmintic for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of External Anthelmintic for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of External Anthelmintic for Dogs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the External Anthelmintic for Dogs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of External Anthelmintic for Dogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of External Anthelmintic for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of External Anthelmintic for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Spray
- Drops
Applications
- Research Institutions
- Veterinary Clinics
- Animal Shelters
- Pet Owners
- Others
Companies covered
- FRONTLINE
- Zoetis
- Bayer
- Virbac
- Vetoquinol
- NexGard
- Merck Animal Health
- Elanco
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global External Anthelmintic for Dogs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global External Anthelmintic for Dogs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global External Anthelmintic for Dogs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global External Anthelmintic for Dogs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global External Anthelmintic for Dogs Market Dynamics
- 2.1 External Anthelmintic for Dogs Industry Trends
- 2.2 External Anthelmintic for Dogs Industry Drivers
- 2.3 External Anthelmintic for Dogs Industry Opportunities and Challenges
- 2.4 External Anthelmintic for Dogs Industry Restraints
3 External Anthelmintic for Dogs Market by Manufacturers
- 3.1 Global External Anthelmintic for Dogs Revenue by Manufacturers (2021-2026)
- 3.2 Global External Anthelmintic for Dogs Sales by Manufacturers (2021-2026)
- 3.3 Global External Anthelmintic for Dogs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global External Anthelmintic for Dogs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global External Anthelmintic for Dogs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global External Anthelmintic for Dogs Manufacturers, Product Type & Application
- 3.7 Global External Anthelmintic for Dogs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global External Anthelmintic for Dogs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 External Anthelmintic for Dogs Players Market Share by Revenue in 2025
- 3.8.3 2025 External Anthelmintic for Dogs Tier 1, Tier 2, and Tier 3
4 External Anthelmintic for Dogs Market by Type
- 4.1 External Anthelmintic for Dogs Type Introduction
- 4.1.1 Spray
- 4.1.2 Drops
- 4.2 Global External Anthelmintic for Dogs Sales by Type
- 4.2.1 Global External Anthelmintic for Dogs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global External Anthelmintic for Dogs Sales by Type (2021-2032)
- 4.2.3 Global External Anthelmintic for Dogs Sales Market Share by Type (2021-2032)
- 4.3 Global External Anthelmintic for Dogs Revenue by Type
- 4.3.1 Global External Anthelmintic for Dogs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global External Anthelmintic for Dogs Revenue by Type (2021-2032)
- 4.3.3 Global External Anthelmintic for Dogs Revenue Market Share by Type (2021-2032)
5 External Anthelmintic for Dogs Market by Application
- 5.1 External Anthelmintic for Dogs Application Introduction
- 5.1.1 Research Institutions
- 5.1.2 Veterinary Clinics
- 5.1.3 Animal Shelters
- 5.1.4 Pet Owners
- 5.1.5 Others
- 5.2 Global External Anthelmintic for Dogs Sales by Application
- 5.2.1 Global External Anthelmintic for Dogs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global External Anthelmintic for Dogs Sales by Application (2021-2032)
- 5.2.3 Global External Anthelmintic for Dogs Sales Market Share by Application (2021-2032)
- 5.3 Global External Anthelmintic for Dogs Revenue by Application
- 5.3.1 Global External Anthelmintic for Dogs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global External Anthelmintic for Dogs Revenue by Application (2021-2032)
- 5.3.3 Global External Anthelmintic for Dogs Revenue Market Share by Application (2021-2032)
6 Global External Anthelmintic for Dogs Sales by Region
- 6.1 Global External Anthelmintic for Dogs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global External Anthelmintic for Dogs Sales by Region (2021-2032)
- 6.2.1 Global External Anthelmintic for Dogs Sales by Region (2021-2026)
- 6.2.2 Global External Anthelmintic for Dogs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America External Anthelmintic for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America External Anthelmintic for Dogs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe External Anthelmintic for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe External Anthelmintic for Dogs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific External Anthelmintic for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific External Anthelmintic for Dogs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa External Anthelmintic for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa External Anthelmintic for Dogs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global External Anthelmintic for Dogs Revenue by Region
- 7.1 Global External Anthelmintic for Dogs Revenue by Region
- 7.1.1 Global External Anthelmintic for Dogs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global External Anthelmintic for Dogs Revenue by Region (2021-2026)
- 7.1.3 Global External Anthelmintic for Dogs Revenue by Region (2027-2032)
- 7.1.4 Global External Anthelmintic for Dogs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America External Anthelmintic for Dogs Revenue (2021-2032)
- 7.2.2 North America External Anthelmintic for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe External Anthelmintic for Dogs Revenue (2021-2032)
- 7.3.2 Europe External Anthelmintic for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific External Anthelmintic for Dogs Revenue (2021-2032)
- 7.4.2 Asia-Pacific External Anthelmintic for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa External Anthelmintic for Dogs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa External Anthelmintic for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 FRONTLINE
- 8.1.1 FRONTLINE Company Information
- 8.1.2 FRONTLINE Business Overview
- 8.1.3 FRONTLINE External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 FRONTLINE External Anthelmintic for Dogs Product Portfolio
- 8.1.5 FRONTLINE Recent Developments
- 8.2 Zoetis
- 8.2.1 Zoetis Company Information
- 8.2.2 Zoetis Business Overview
- 8.2.3 Zoetis External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Zoetis External Anthelmintic for Dogs Product Portfolio
- 8.2.5 Zoetis Recent Developments
- 8.3 Bayer
- 8.3.1 Bayer Company Information
- 8.3.2 Bayer Business Overview
- 8.3.3 Bayer External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer External Anthelmintic for Dogs Product Portfolio
- 8.3.5 Bayer Recent Developments
- 8.4 Virbac
- 8.4.1 Virbac Company Information
- 8.4.2 Virbac Business Overview
- 8.4.3 Virbac External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Virbac External Anthelmintic for Dogs Product Portfolio
- 8.4.5 Virbac Recent Developments
- 8.5 Vetoquinol
- 8.5.1 Vetoquinol Company Information
- 8.5.2 Vetoquinol Business Overview
- 8.5.3 Vetoquinol External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Vetoquinol External Anthelmintic for Dogs Product Portfolio
- 8.5.5 Vetoquinol Recent Developments
- 8.6 NexGard
- 8.6.1 NexGard Company Information
- 8.6.2 NexGard Business Overview
- 8.6.3 NexGard External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 NexGard External Anthelmintic for Dogs Product Portfolio
- 8.6.5 NexGard Recent Developments
- 8.7 Merck Animal Health
- 8.7.1 Merck Animal Health Company Information
- 8.7.2 Merck Animal Health Business Overview
- 8.7.3 Merck Animal Health External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Merck Animal Health External Anthelmintic for Dogs Product Portfolio
- 8.7.5 Merck Animal Health Recent Developments
- 8.8 Elanco
- 8.8.1 Elanco Company Information
- 8.8.2 Elanco Business Overview
- 8.8.3 Elanco External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Elanco External Anthelmintic for Dogs Product Portfolio
- 8.8.5 Elanco Recent Developments
- 8.9 Boehringer Ingelheim
- 8.9.1 Boehringer Ingelheim Company Information
- 8.9.2 Boehringer Ingelheim Business Overview
- 8.9.3 Boehringer Ingelheim External Anthelmintic for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Boehringer Ingelheim External Anthelmintic for Dogs Product Portfolio
- 8.9.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 External Anthelmintic for Dogs Value Chain Analysis
- 9.1.1 External Anthelmintic for Dogs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 External Anthelmintic for Dogs Production Mode & Process
- 9.2 External Anthelmintic for Dogs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 External Anthelmintic for Dogs Distributors
- 9.2.3 External Anthelmintic for Dogs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst